SCHEMBL1937059

SCHEMBL1937059

CNC(=O)c1c(-c2ccc(F)cc2)nn2cc(F)c(-c3cc(C(=O)N(c4ccccc4)C4CC4)ccc3C)cc12

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP2C8 P10632 6/20 0.36
KCNH2 Q12809 3/20 0.36
CYP3A4 P08684 6/20 0.36
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
NR1I2 O75469 1/20 0.34
BRD4 O60885 1/20 0.34
MAPK14 Q16539 5/20 0.33
LCK P06239 2/20 0.32
KIT P10721 2/20 0.32
KDR P35968 2/20 0.32
MAPK13 O15264 1/20 0.32
TACR1 P25103 1/20 0.32
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1935409 0.84 CYP2C8 (0.38) CYP2C8KCNH2CYP3A4MEN1KMT2A
SCHEMBL2431980 0.84 CYP2C8 (0.38) CYP2C8KCNH2CYP3A4MEN1KMT2A
SCHEMBL2468512 0.84 MAPK14 (0.39) CYP2C8KCNH2CYP3A4MEN1KMT2A
SCHEMBL17530686 0.84 CYP3A4 (0.33) CYP2C8KCNH2CYP3A4CYP2C9CYP2C19
SCHEMBL2409322 0.84 CYP2C8 (0.38) CYP2C8KCNH2CYP3A4MEN1KMT2A
SCHEMBL1934988 0.80 CYP2C8 (0.57) CYP2C8KCNH2CYP3A4NR1I2MAPK14
SCHEMBL12187969 0.79 CYP2C8 (0.56) CYP2C8KCNH2CYP3A4NR1I2MAPK14
SCHEMBL17530639 0.79 ALDH1A1 (0.40) CYP2C8KCNH2CYP3A4NR1I2ALDH1A1
SCHEMBL1936514 0.75 ALDH1A1 (0.45) CYP2C8KCNH2CYP3A4NR1I2MAPK14
SCHEMBL1920481 0.74 CYP2C8 (0.65) CYP2C8KCNH2CYP3A4NR1I2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2331502-A2 COMPOUNDS FOR THE TREATMENT OF HEPATITIS C Bristol-Myers Squibb Company (US) 2011-06-15 EP disclosed